conv.

← The whole story
Health
Nirsevimab Cuts RSV ICU Admissions by 97% in Ontario, Quebec Infants

University of Calgary details SPRINT-KIDS study results

The university's release, echoed by Medical Xpress, describes the JAMA Network Open study analyzing 2024-2025 RSV season data from seven pediatric hospitals in Ontario and Quebec, with lead researchers quantifying effectiveness against hospitalization and ICU admission.

University of Calgary details SPRINT-KIDS study results
byteseu.com

“The results were dramatic. Nirsevimab effectiveness against hospitalizations was 79 per cent, and 97 per cent against ICU admissions.”

Dr. Sarah Buchan

Dr. Sarah Buchan First author; scientific lead, Communicable Disease Control, Public Health OntarioDr. Stephen Freedman Senior author; SPRINT-KIDS project lead, University of CalgarySPRINT-KIDS Network Research surveillance network

The whole story articlespostscomments the bright band is this development · numbered dots are the others · click one to jump

Peak 3 pieces in 3h at Sep 14, 2 PM; 9 pieces over 10 days (4 articles · 2 posts · 3 comments) Sep 14, 2 PM — 3 pieces · 3 articles — Google News 3Sep 14, 5 PM — quietSep 14, 8 PM — quietSep 14, 11 PM — quietSep 15, 2 AM — quietSep 15, 5 AM — quietSep 15, 8 AM — quietSep 15, 11 AM — quietSep 15, 2 PM — quietSep 15, 5 PM — 1 piece · 1 post — Reddit 1Sep 15, 8 PM — 3 pieces · 1 post · 2 comments — Reddit 2, Mastodon 1Sep 15, 11 PM — 1 piece · 1 comment — Reddit 1Sep 16, 2 AM — quietSep 16, 5 AM — quietSep 16, 8 AM — quietSep 16, 11 AM — 1 piece · 1 article — Google News 1Sep 16, 2 PM — quietSep 16, 5 PM — quietSep 16, 8 PM — quietSep 16, 11 PM — quietSep 17, 2 AM — quietSep 17, 5 AM — quietSep 17, 8 AM — quietSep 17, 11 AM — quietSep 17, 2 PM — quietSep 17, 5 PM — quietSep 17, 8 PM — quietSep 17, 11 PM — quietSep 18, 2 AM — quietSep 18, 5 AM — quietSep 18, 8 AM — quietSep 18, 11 AM — quietSep 18, 2 PM — quietSep 18, 5 PM — quietSep 18, 8 PM — quietSep 18, 11 PM — quietSep 19, 2 AM — quietSep 19, 5 AM — quietSep 19, 8 AM — quietSep 19, 11 AM — quietSep 19, 2 PM — quietSep 19, 5 PM — quietSep 19, 8 PM — quietSep 19, 11 PM — quietSep 20, 2 AM — quietSep 20, 5 AM — quietSep 20, 8 AM — quietSep 20, 11 AM — quietSep 20, 2 PM — quietSep 20, 5 PM — quietSep 20, 8 PM — quietSep 20, 11 PM — quietSep 21, 2 AM — quietSep 21, 5 AM — quietSep 21, 8 AM — quietSep 21, 11 AM — quietSep 21, 2 PM — quietSep 21, 5 PM — quietSep 21, 8 PM — quietSep 21, 11 PM — quietSep 22, 2 AM — quietSep 22, 5 AM — quietSep 22, 8 AM — quietSep 22, 11 AM — quietSep 22, 2 PM — quietSep 22, 5 PM — quietSep 22, 8 PM — quietSep 22, 11 PM — quietYesterday, 2 AM — quietYesterday, 5 AM — quietYesterday, 8 AM — quietYesterday, 11 AM — quietYesterday, 2 PM — quietYesterday, 5 PM — quietYesterday, 8 PM — quietYesterday, 11 PM — quietToday, 2 AM — quietToday, 5 AM — quiet 1–23–4
Sep 15Sep 16Sep 17Sep 18Sep 19Sep 20Sep 21Sep 22now · 6:46 AM ET

What was reported 1 claim about this development

  1. first by University of Calgary, 9d ago · also Medical Xpress

    1 more headline

All 4 developments of Nirsevimab Cuts RSV ICU Admissions by 97% in Ontario… →

Google NewsRedditMastodon